PGP and leukemia: In one study, a drug screen testing for active combinations with FK866 in primary leukemia cells identified cyclosporin A, a calcineurin inhibitor and a P-GP/ABCB1 inhibitor, as an enhancer of NAMPT inhibitor activity.